Summit Healthcare Acquisition Corp.
Status: Deal Closed
U=S+W/2
W=S@11.5
IPO Proceeds, $M | $200.00M |
---|---|
IPO Date | Jun 9, 2021 |
CEO | Bo Tan |
Left Lead | BofA Securities |
IPO Cash in Trust | 100.0% |
SPAC Tenor | 24 months |
IPO Sector |
Healthcare
Healthcare in Asia |
IPO Geography | Asia |
Target Company | YS Biopharma |
Deal Announced | Sep 29, 2022 |
Deal Size, $M | $849.00M |
Deal Sector | Healthcare |
Deal Geography | Global |
SEC Filings | www.sec.gov |
Approval Vote | Mar 14, 2023 |
Amendment Vote | TBD |
Closing Date | Mar 16, 2023 |
Formerly SMIH
YS
YSBPW
Price | $0.71 |
---|---|
Last closing price | $0.71 |
H/L, today | $0.66 / $0.73 |
H/L, 52-week | $0.38 / $12.93 |
Volume, today | 49,756 |
Volume, 3-month avg. | N/A |
Price | |
---|---|
Volume, today | |
Volume, 3-month avg. | N/A |
Price | $0.07 |
---|---|
Last closing price | $0.08 |
High/low price, today | $0.07 / $0.07 |
High/low price, 52-week | $0.03 / $0.28 |
Volume, today | 1,458 |
Volume, 3-month avg. | N/A |
Price | |
---|---|
Volume, today | |
Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in for more on Summit Healthcare Acquisition Corp.:
- Structure and cap table
- 5 directors & officers
- 16 filings and events
- 2 underwriters
- 5 legal advisors
Structure
Sign in to view structure, cap table, and calendar of events.
Team
Name | Age | Title |
---|---|---|
Bo Tan | 47 | CEO, Co-CIO & Director |
Ken Poon | 54 | President, Co-CIO & Director |
Ian Stone | 70 | Director |
Thomas Folinsbee | 53 | Director |
Tao Bai | 56 | Director |
Sign in to view team biographies and more sponsor and affiliate data.
Advisors
Underwriters
BofA Securities | BR | 19,500,000 | units |
Futu Securities | 500,000 | ||
20,000,000 | units | ||
Up-Front UW fee | 2.00 | % | |
Deferred UW fee | 3.50 | % |
Sign in to view more advisor data.
Deal
Sign in to view merger details and deal financials.
Filings
Sign in to view 16 filings.